A story about how I realized this is how applied math skills are acquired

It started with the recurrence relation function on the Casio FX-GC100 graphing calculatorSince a recurrence relation is ...
x

гам on X: "@subcountability yeah that's pretty much exactly why it is a typing rule. if F is built from type formers you get F(f) by recursion on its syntax like haskell ...

@subcountability yeah that's pretty much exactly why it is a typing rule. if F is built from type formers you get F (f) by recursion on its syntax like haskell deriving fmap as long as X only occurs ...
x

Cubase Enjoyer on X: "@eeuoss @valigo Depends on whether the compiler has tail call optimisation. If you use Scala or Haskell, recursion is totally viable"

Cubase Enjoyer on X: "@eeuoss @valigo Depends on whether the compiler has tail call optimisation. If you use Scala or Haskell, recursion is totally viable" Eugene Ostroukhov @eeuoss 3h ...
Seeking Alpha

Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
CBSSports.com

2026 Haskell Stakes predictions, horses, odds, post positions: Surprising picks from elite racing expert

Further Ado will look to get back in the conversation as one of the top 3-year-olds in the country when he runs in the 2026 Haskell Stakes on Saturday at Monmouth Park. Two starts ago he finished 11th ...
Yahoo Finance

Recursion’s AI Drug Pipeline Progress Tests Investor Patience And Valuation

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

Recursion Pharmaceuticals Inc (RXRX): Is AI Strategy Working?

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Motley Fool

Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.

Recursion Pharmaceuticals also argues that it could reduce the time from discovery to the start of clinical trials. All of this would lead to less time and money spent on developing therapies that are ...
STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...
Forbes

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
The Motley Fool

Where Will Recursion Pharmaceuticals Be in 5 Years?

Recursion Pharmaceuticals uses AI to improve the process of discovering and developing drugs, making it easier and more cost-effective. Most medicines that enter clinical trials never reach the market ...
Fox News

Hollywood heir accused of beheading wife, in-laws dies in custody days before release of key evidence

Sam Haskell IV, the Hollywood scion accused of chopping up his wife and in-laws before tossing a disembodied torso into a dumpster, has died in a Los Angeles jail while awaiting trial, according to ...